Sengkang General Hospital, Sengkang Community Hospital and Punggol Polyclinic give the North-East Singapore region an established healthcare-service base, but their presence does not guarantee that a small local company can become a supplier. The realistic business opportunities between 2027 and 2037 involve understanding how public healthcare purchases equipment, medical and non-medical supplies, logistics and services; what professional and product regulation applies; and how to prove safety, reliability and value. This guide is for entrepreneurs, established SMEs and readers interested in the business system behind healthcare, not an advertisement for treatment, a forecast of patient numbers or a list of jobs.

As at 1 November 2026, Sengkang General Hospital describes itself as an integrated hospital campus co-located with Sengkang Community Hospital, serving residents across Singapore’s North-East. SingHealth Polyclinics lists its Punggol clinic at Oasis Terraces, 681 Punggol Drive. ALPS, the public-healthcare supply-chain organisation, says it purchases medicines, medical and non-medical supplies, equipment and services for the three public healthcare clusters and publishes sourcing events. Its vendor guidance was updated in October 2026. These verified arrangements show that healthcare procurement is structured and often wider than one hospital; an entrepreneur should investigate the actual sourcing route before making sales claims.

• Local healthcare anchor: Sengkang General Hospital, Sengkang Community Hospital and Punggol Polyclinic.
• Wider market: Singapore’s public healthcare clusters, private providers, community-care organisations and approved distributors, where relevant.
• Supplier categories: Non-medical consumables, logistics, maintenance, facility services, approved medical devices, software and correctly authorised healthcare activities.
• Procurement gateway: ALPS and applicable institution or cluster sourcing processes; not every product is purchased separately by an individual hospital.
• Critical requirements: Product classification, HSA licensing and registration where applicable, procurement documentation, quality systems, confidentiality and patient safety.
• Important distinction: Selling office supplies is not equivalent to importing or wholesaling a medical device or providing a licensed clinical service.
• Commercial test: Can the business meet a clearly defined specification, withstand qualification and delivery costs, and support the product after the sale?
• 2027–2037: A scenario horizon for responsible suppliers, not a promised increase in tenders, revenue or healthcare licences.

Healthcare is a service system and a supply-chain system

When residents think of a hospital, they naturally think of doctors, nurses and patients. Behind the visible care are records, laboratory services, equipment, cleaning, procurement, food, linen, facilities, deliveries, security and many kinds of specialist support. A hospital must make all these activities work together while preserving safety and confidentiality. That makes healthcare an industry with many kinds of buyers and risk levels. It does not mean that every firm is qualified to participate in every activity.

A company selling an ordinary office product may face standard commercial specifications, whereas a company importing implantable medical equipment faces a different regulatory environment. A software vendor handling sensitive patient records has obligations unlike a general appointment-reminder supplier with synthetic demonstration data. A catering contractor, laundry provider and regulated clinical laboratory all require their own analysis. The first question is therefore not “How do I supply Sengkang Hospital?” It is “What exactly will I supply, who buys it and which requirements apply to this activity?”

Why Sengkang matters to the North-East business catchment

Sengkang General Hospital’s official description explains that it serves residents in the North-East and operates alongside Sengkang Community Hospital. The campus supports different stages of care, including specialist and longer-term rehabilitation needs. Punggol Polyclinic at Oasis Terraces provides a separate community-facing public care setting within Punggol. A business examining the region should understand these distinct institutional functions rather than use the word hospital as shorthand for every healthcare activity.

The surrounding Punggol, Sengkang, Seletar and Pasir Ris communities are economically relevant because healthcare workers, patients, caregivers and suppliers travel through them. Yet patients are not commercial leads to be approached in waiting areas, and a clinic’s visitor traffic is not evidence that a nearby retail outlet will earn a particular income. This article concentrates on legitimate business-to-business procurement and supply-chain operations. Consumer shopping and neighbourhood retail have a separate business-viability guide.

Public healthcare purchasing is often organised beyond one institution

ALPS states that it purchases drugs, medical and non-medical supplies, equipment and services for Singapore’s three public healthcare clusters and institutions. Group or national contracts can aggregate requirements, although certain cluster or institution arrangements remain relevant. This is important for a supplier because an employee at one hospital may not be able to authorise the product the entrepreneur wants to sell. The purchasing decision may be run through a formal platform or by a separate procurement team.

ALPS’s October 2026 process guidelines describe its supplier sourcing events and the use of SAP Business Network for eProcurement and awarded-supplier invoicing. The organisation also publishes a forward-looking sourcing calendar, with schedules expressly subject to change. A company should consult current official instructions, register properly where eligible and read the scope of each sourcing event. It must not treat an indicative calendar as a final invitation, a tender award or proof that a locally manufactured product will be preferred.

Choosing between a product business and a service business

A product supplier provides a specific item under a specification: for example, an approved consumable, a piece of equipment or a non-medical supply. A service company may maintain facilities, manage authorised logistics, carry out support tasks or provide an IT system. Each model has different cash flow. A product supplier may have to hold inventory and meet delivery windows. A service provider may carry more staff cost and ongoing performance obligations.

Some businesses combine both. An equipment supplier might sell a machine together with installation, training and maintenance. That can create recurring value but also introduces warranty and competence requirements. If the equipment is a regulated medical device, the additional commercial services do not remove HSA obligations. A founder should map the entire customer relationship from approval through delivery, use, faults and end-of-life handling. What appears to be a one-off sale may create several years of responsibility.

What counts as a medical device is not always obvious

The Health Sciences Authority regulates medical devices according to their intended purpose and risk. It provides official tools to help businesses determine whether a product is a medical device and how it should be classified. The categories include lower-risk items and higher-risk devices whose malfunction can have very serious consequences. A product’s attractive appearance or technological sophistication does not determine its classification; its intended medical use and applicable rules do.

HSA’s 2026 guidance explains that Class A devices are generally exempt from product registration but subject to relevant notification and dealer obligations. Higher-risk products generally need appropriate registration or a lawful exception. This is a reason to classify a product before importing it or advertising it to healthcare buyers. A company should not assume that calling a device a wellness gadget makes regulation irrelevant if it is actually intended for medical use. Seek regulatory advice where needed, and never use this article as a substitute for HSA’s current requirements.

Dealer licensing is a separate question from device registration

HSA’s June 2026 dealer guidance distinguishes the activities of manufacturing, importing and wholesaling medical devices. The relevant dealer licence is tied to what the business does. Importing a device, supplying it wholesale and making or packaging devices are not interchangeable activities. HSA explains that a wholesaler’s licence is not needed merely for supply to end-users in a retail shop, but that observation must not be misread as an exemption from all medical-device product and business rules.

A prospective dealer should identify the full chain of transactions. Who imports the device? Who holds legal responsibility for marketing it? Who stores it, sells it and handles complaints? Is it being supplied as a commercial sample? HSA’s quality-management and licensing requirements must be checked against the planned arrangement. If a firm is only providing an unrelated administrative service, it should not call itself a licensed medical-device importer. Accurate description protects patients, buyers and the supplier’s credibility.

Product quality is a continuing responsibility

Healthcare equipment can be used in circumstances where an avoidable failure may harm a person. Buyers therefore care about technical specifications, handling, traceability, documentation, training and after-sales support. Medical-device dealers can have post-market responsibilities, including reporting defined adverse events and carrying out necessary corrective actions. Quality cannot be reduced to a certificate copied onto the front page of a sales deck. The system must actually work.

A supplier should know how it handles a defective product. Which lot or serial number was supplied to which customer? Who contacts the institution if a problem is discovered? Can the firm quarantine stock that should not be delivered? How will it document a corrective action and prevent the same error? For ordinary non-medical supplies the details may be simpler, but accurate records remain useful. Healthcare buyers value businesses that can explain a problem promptly and provide verifiable evidence of what happened.

Medical devices are not the same as healthcare services

A company may sell an approved product without being licensed to deliver every clinical service in which it could be used. The Ministry of Health states that the Healthcare Services Act regulates defined types of healthcare service under a services-based framework. Its October 2026 overview lists 16 regulated healthcare services requiring the relevant HCSA licences. Examples include acute hospital care, clinical laboratory service, certain outpatient services, radiological service and medical transport service.

This distinction matters for founders offering remote monitoring, mobile services, screening or transport. A software subscription, a regulated diagnostic service and an equipment sale can have different obligations. A company must decide what its employees actually do, what claims it makes and whether its proposed activity falls within a regulated category. If it does, obtain the necessary licence before operating. A business cannot bypass service regulation by describing itself only as a technology platform when the underlying activity is regulated care.

The non-medical supply chain can still be demanding

Not every contract involves an HSA-regulated device. Hospitals may purchase paper, cleaning materials, office equipment, furniture, selected logistical services and other non-medical goods. These businesses can be suitable for SMEs with proven competence, but procurement specifications and vendor requirements still apply. A buyer may demand precise delivery schedules, sustainability information, approved packaging, invoicing procedures or continuity arrangements.

A non-medical supplier should avoid assuming the process will be informal because the item looks ordinary. The scale of a public healthcare group contract may require reliable fulfilment across institutions. A company that can deliver to one small shop may not yet have the systems to handle high-volume orders, returns and multiple locations. The first step is to assess actual capacity honestly. A business can grow through a smaller contract or approved subcontracting arrangement where the buyer permits it, rather than overpromise and risk missed deliveries.

Medical logistics is a chain of custody

A medical supply may need specific storage, tracking or delivery conditions. Requirements depend on the product, its classification and the instructions of the responsible manufacturer or organisation. A temperature-sensitive pharmaceutical, a general office shipment and a medical device cannot all be treated as interchangeable parcels. The logistics operator needs to understand the applicable conditions before accepting responsibility.

Chain of custody means more than having a driver say a parcel was delivered. It may involve identifying the item, recording handovers, verifying the intended recipient, documenting any temperature excursion and maintaining an escalation process. If a shipment arrives damaged or outside accepted conditions, the customer needs to know promptly. The operator should never decide on its own that a sensitive product remains suitable for clinical use after a deviation. That decision belongs to the appropriately responsible authorised party.

Why inventory forecasting matters to healthcare buyers

Running out of a needed item can disrupt service; holding too much stock increases cost and the risk of expiry. Suppliers and institutions therefore benefit from accurate forecasting, agreed replenishment, stock rotation and reliable supplier communication. A simple system may provide much of the value. If employees spend hours chasing a delivery confirmation, better documentation and a clear contact may help before any sophisticated algorithm is added.

Forecasting should incorporate uncertainty. Changes in demand, supplier availability and product replacement cycles can affect inventory requirements. A business promising complete automation should explain what happens when its forecast is wrong. Can authorised staff override a proposed order? Does the system flag expiry dates correctly? Is there an audit trail? This is a promising market for dependable operational services, but the commercial claim must be based on measurable performance, not a claim that artificial intelligence eliminates shortages.

Procurement integrity is part of supplier credibility

Selling to public healthcare organisations means respecting tender rules, conflict-of-interest safeguards, confidentiality and the customer’s legitimate decision process. A founder should avoid offering benefits that could improperly influence a buyer, inventing previous public-sector experience or implying that an informal conversation constitutes approval. The correct route is to review the stated requirements, submit a compliant response and ask procedural questions through the authorised channel.

A tender may also contain conditions that a small supplier cannot satisfy. That is not an invitation to conceal missing competence. The business should decide whether to build capability for future opportunities, partner under permitted arrangements or remain outside that market. An honest no-bid decision protects the company’s cash and reputation. A supplier that understands the paperwork, delivery responsibilities and support obligations will generally make more credible long-term plans than one that pursues every available notice.

One hospital contract can require national logistics

The phrase local hospital supplier may suggest a company near Sengkang delivering only to that campus. In practice, aggregated healthcare procurement can cover several institutions and geographic areas. A supplier may need to support a national framework, multiple delivery points, central ordering or a network of authorised distributors. That can create opportunity for efficient businesses but also significant costs.

Before bidding, model the delivery network. Which locations are included? Are there fixed windows or controlled receiving points? Who pays for returns, urgent orders and documentation? What happens if a vehicle fails? A business based in Punggol may have a useful regional position but still need partners elsewhere in Singapore. Location should be evaluated against the real requirements of the contract, not the founder’s hope that being close to one hospital will lead to preferential treatment.

Software for healthcare requires a privacy-first design

Healthcare organisations manage sensitive patient information. A developer pitching an application should begin with the minimum data necessary for its purpose, obtain proper authority and design access controls, logs and secure handling. A public demonstration should use synthetic or otherwise properly authorised data, not a copied patient list. Even staff scheduling or asset-management systems may reveal confidential information about personnel or operations. Security is therefore an enterprise requirement, not simply a feature to add once a buyer expresses interest.

A software team needs a clear description of where data is processed, how access is granted, what external services are used and how a contract ends. If an AI system produces uncertain results, a qualified person should know the limits and retain responsibility for decisions that require professional judgment. A product should never market itself as diagnosing patients, replacing clinical oversight or producing guaranteed health outcomes without the appropriate evidence and regulatory basis.

Clinical judgment must not be hidden inside a software promise

A business may wish to sell decision-support tools, remote screening services or patient-facing applications. The ethical risk is overselling what software can do. A reminder or administrative tool is different from a system intended to diagnose, recommend treatment or triage serious medical conditions. The latter can involve different medical-device, service and professional requirements. The founder should define the intended use before development, not wait until the marketing department needs a stronger slogan.

A cautious path is to test administrative improvements first, with authorised users and a clearly defined role. Does the software reduce duplicate paperwork? Can it identify missing fields without inventing content? Does it preserve the original records? The business may learn valuable lessons about reliability without entering a more sensitive clinical category. When a proposed feature changes the intended medical purpose, the team should reassess regulatory obligations before releasing it.

Maintenance and calibration are specialised service businesses

Healthcare equipment can require periodic servicing, performance checks and calibration under the manufacturer’s instructions and institutional requirements. A company that handles ordinary electrical appliances may not be qualified to service clinical equipment. The purchaser may need evidence of technician training, controlled parts, appropriate tools, service documentation and the ability to identify when a device must not be used. The exact obligations depend on the equipment and the regulated work involved.

A supplier should define its maintenance scope in writing. Which models are included? Does it have access to the authorised procedures? Who decides whether equipment can return to service? Are replacement components approved? How are failures reported? If a company lacks the competence, it should not improvise. A narrowly specialised firm with reliable service records can be commercially attractive, but the service must support safety rather than make bold promises about rapid repair regardless of risk.

Accessibility and rehabilitation create questions about the user

Sengkang Community Hospital’s co-location with Sengkang General Hospital highlights the importance of different stages of care. Businesses may see opportunities in accessible equipment, communications support, rehabilitation-related technology or ordinary facility services. However, the people using such products are not interchangeable. An older person, a recovering patient and a caregiver may have different abilities, expectations and concerns. Product development should involve appropriate professional and user input where lawful.

Accessibility products are useful only when they solve a real problem safely. A screen that looks clear in a marketing image may be difficult for a user with impaired vision. A device that requires complex setup may impose work on caregivers. A supplier should observe permitted use carefully, test understandable instructions and record failure modes. Products making medical claims need the appropriate assessment. A commercial narrative about helping people should never substitute for genuine product safety or professional oversight.

A hospital is not a public testbed for any new invention

Entrepreneurs may imagine that a nearby hospital will readily allow them to test equipment with patients. That is not a safe assumption. Research, clinical trials, data access and product evaluation may require ethics review, institutional approval, consent and regulatory pathways depending on the activity. Even seemingly harmless surveys can raise privacy and patient-welfare concerns. Do not approach patients in clinical areas or collect their personal information as part of an unsanctioned sales experiment.

Many ideas can be tested without touching clinical systems. A company can use synthetic data, speak with authorised procurement professionals, prototype a non-clinical workflow or evaluate equipment in an appropriate simulated environment. The test should state what it can and cannot prove. If a study eventually requires hospital participation, the team must use the institution’s actual partnership and approval process. Trust is too important to sacrifice for the appearance of a dramatic pilot.

Financial planning: qualification can take longer than development

A startup may spend money on prototypes, testing, licences, technical documentation and professional advice before a healthcare customer places an order. Tender cycles and customer approvals may extend the period without substantial revenue. This makes cash-flow planning essential. A company cannot assume an impressive demonstration will immediately produce a purchase order or that a first contract will cover all development expenditure.

Consider a fictional medical-device business with S$45,000 in preparation and testing expenses, S$12,000 of continuing monthly overhead and a potential first order that may or may not arrive within six months. Even before inventory, the six-month cash requirement could reach S$117,000. Those are invented teaching figures, not typical HSA fees or an actual hospital supplier budget. The lesson is to estimate downside exposure, confirm requirements and secure appropriate financing before committing to expensive development.

Service-level agreements can make or break the margin

Healthcare buyers may require prompt delivery, equipment uptime, replacement support or incident response. A supplier needs to calculate how those obligations affect staffing and inventory. An apparently profitable equipment sale can become expensive if the warranty promises unlimited attendance or free replacement without realistic conditions. The company must also distinguish what it can control from events outside its scope, while maintaining customer protection and legal compliance.

Prepare several cost scenarios. One includes normal deliveries and routine support. Another includes a recall, a critical equipment fault or a prolonged supplier delay. The firm should budget for qualified escalation staff and document who decides what happens next. A sustainable supplier does not avoid responsibility by writing vague terms; it identifies foreseeable obligations and prices its service accordingly. In healthcare, reliability is a commercial feature that must be genuinely delivered.

Non-medical innovation may offer a lower-risk first contract

Not every meaningful improvement requires entering a clinical workflow. A company might provide secure administrative tools, efficient non-medical deliveries, accessible signage, equipment tracking or facilities support. Even these services need appropriate information security and procurement approval, but they may allow a business to develop institutional competence without making medical claims. A founder should choose a problem that fits present capabilities and advance deliberately.

A small printer of durable labels, for example, might discover that customers need better inventory identification. It should understand relevant specifications and testing requirements before changing materials. A logistics firm might improve proof-of-delivery records for approved non-sensitive supplies. Such opportunities can sound less glamorous than a diagnostic AI product, yet they may create repeat revenue and teach the firm how public healthcare procurement works. Honest specialisation builds a stronger foundation for future growth.

An example: a small Punggol software company

Imagine a team that builds a digital request tracker for authorised facilities personnel. It begins with synthetic work orders and records exactly which actions users can perform. The product does not store patient diagnoses, does not control clinical equipment and does not make medical decisions. The team demonstrates that staff can locate outstanding tasks and confirm who has responsibility for resolving them. It estimates the time currently lost to duplicated communications.

The buyer then asks about procurement eligibility, security and integration with existing systems. The team assesses those requirements instead of quietly connecting to a live database. It may offer a limited, formally authorised trial or decide that the integration is beyond its capacity. This is a credible commercial process. The fact that a company is located near Punggol Digital District does not grant hospital access, but disciplined design can make future conversations more productive.

An example: a specialist medical-supply distributor

A legitimate distributor wants to supply a specific category of medical device. It first uses HSA guidance to classify the product, determine product registration or notification needs, and identify its own importer or wholesaler responsibilities. It verifies the manufacturer’s information and builds a quality-management and traceability process appropriate to its activity. Only then does it approach eligible customers through their stated procurement processes.

The distributor’s offer includes delivery, user documentation, complaint handling and replacement support where appropriate. It does not claim that every product is endorsed by a hospital or automatically approved for all clinical uses. If a model change requires a regulatory notification or further assessment, the firm responds before selling the updated version. This disciplined business may grow more slowly than an aggressively marketed distributor, but it is better positioned to remain trustworthy.

An example: an ordinary-service SME serving an institution

A cleaning, printing or non-medical logistics company may have strong experience in commercial buildings. It evaluates healthcare requirements without assuming they are identical to those of an office tower. The prospective institution may impose distinct operating hours, infection-control instructions, handling constraints, confidentiality and incident procedures. The SME maps each difference and determines whether its workforce and pricing can support them.

A contract may be financially unsuitable even if the prestige of the customer is attractive. A business that needs an entirely separate shift, additional supervision or a specialised vehicle must include those costs in its bid. A founder should not ask staff to ignore safe procedures to preserve the price quoted. The objective is profitable, compliant work that helps the institution function, not a logo on a customer slide.

2027–2029: establish a genuine qualification pathway

During the early years of the 2027–2037 planning horizon, prospective suppliers can study ALPS sourcing categories, determine their regulatory status and document service capability. The first important outcome may be learning that a product needs further approval or that a contract is national rather than local. A company that recognises this before spending substantial money has already improved its decision-making.

Plans should incorporate delays. Public procurement, product registration, training and partner agreements can take time. Keep an existing customer base where feasible while assessing healthcare entry. Avoid basing payroll on a tender that has not been awarded. A business may instead start with non-medical institutional work, provided it meets the relevant requirements. These are strategic options, not confirmed procurement programmes or promised work in Sengkang.

2030–2033: prove reliable service across a larger system

If a firm wins suitable work, the next challenge is repeatability. A supplier servicing one institution may later seek additional contracts, but it needs consistent traceability, staff competence, customer support and cybersecurity controls. Adding customers can make an apparently successful business fragile if every incident still depends on the founder’s personal attention. Mature documentation allows others to deliver the same approved service safely.

Digital improvements may reduce avoidable administration, but should be evaluated as tools within a dependable process. The firm should track on-time delivery, complaints, rejected items, recall readiness and actual support costs. It must not invent healthcare outcome measures to impress investors. Whether expansion is appropriate in 2030–2033 depends on customer demand and approved competence, not on the calendar alone.

2034–2037: longevity depends on safe adaptation

Over ten years, clinical devices, information systems and procurement practices may change. A product that is relevant in 2027 could be replaced by a different technology by 2037. A supplier should plan how to maintain service during transitions, protect records and support existing contracts. It may need additional training or different licensing if its activities change. These responsibilities are business risks, not reasons to avoid innovation.

The mature organisation should review dependence on one manufacturer, one hospital contract or one technical specialist. It also needs a plan for product recalls, cybersecurity incidents and loss of key employees. Long-term resilience comes from quality processes, honest communication, trained people and financial reserves. The goal is not to forecast the exact medical supply catalogue of 2037. It is to build a supplier that can continue meeting obligations as technology and demand evolve.

A practical supplier-entry checklist

• Define exactly what product or service the company intends to supply.
• Identify whether it is a medical device, regulated healthcare service, ordinary good or non-clinical service.
• Use current HSA and MOH rules to determine applicable licensing, registration and professional obligations.
• Identify the actual buyer, national contract process or institution sourcing route.
• Confirm whether the company can meet the specification and required quality-management controls.
• Determine who imports, manufactures, warehouses, delivers and handles complaints.
• Establish traceability, authorised user instructions and escalation for safety incidents.
• Map data use and confidentiality before seeking access to any healthcare system.
• Calculate qualification, stock, support and worst-case cash requirements.
• Review procurement integrity, warranty, insurance and contract-exit conditions.
• Prepare genuine references and written evidence of competence.
• Decline work outside the organisation’s authorised or technical scope.

These questions are not obstacles that a clever sales pitch can overcome. They are part of why healthcare organisations can trust a supplier. Accurate answers help a cautious buyer distinguish a serious company from one that has not considered what happens after a product is delivered.

Frequently asked questions

Can a Punggol SME sell directly to Sengkang General Hospital?

Possibly, where it meets the relevant procurement and technical requirements. But ALPS handles a substantial range of public healthcare purchasing across institutions and clusters, so some contracts are not bought independently by individual hospitals. Check the current sourcing process for the precise category.

Does every supplier need a medical-device dealer’s licence?

No. It depends on what the business does and whether the product is a regulated medical device. HSA describes importer, wholesaler and manufacturer licence requirements. An ordinary non-medical stationery supplier faces different obligations. Product classification should precede any licensing conclusion.

Are Class A medical devices completely exempt from regulation?

No. HSA generally exempts Class A devices from product registration but still describes applicable notification and dealer obligations. Other rules can also apply. Always review the current HSA category and business-activity guidance.

Can a startup test a healthcare product on hospital patients?

Not simply because the hospital is nearby. Clinical research, device evaluation, data access and patient engagement can require institutional, ethics and regulatory approvals. Use approved pathways and never gather patient information or conduct clinical experiments without appropriate permission.

Is Punggol Polyclinic part of Sengkang General Hospital?

Punggol Polyclinic is listed by SingHealth Polyclinics at Oasis Terraces. It is a distinct public healthcare setting, not a department that should automatically be treated as part of the Sengkang General Hospital campus.

Will public healthcare spending guarantee strong supplier profits through 2037?

No. A supplier’s results depend on awarded work, qualification cost, competition, reliable delivery, support expenses and payment arrangements. A growing need for care does not guarantee revenue for an individual company.

Your Next Step: understand the buyer before building the product

Start with one legitimate problem, one accurately defined product or service and one authorised purchasing route. Verify whether HSA, MOH or other regulators apply, then determine what evidence the buyer needs to assess quality, safety and value. Make a conservative cash-flow model and calculate the cost of maintaining the service after delivery. Only then commit to stock, specialist equipment or substantial marketing.

Official information: Sengkang General Hospital’s institutional overview, SingHealth Polyclinics’ Punggol location, ALPS supplier process guidelines, updated October 2026, ALPS national sourcing events, HSA’s medical-device regulatory overview, HSA’s dealer-licensing guidance and MOH’s Healthcare Services Act overview, updated October 2026. Requirements, sourcing schedules and product status can change after this article’s November 2026 publication date.